Texas Attorney General Ken Paxton announced a $63 million statewide opioid settlement with Endo Pharmaceuticals, Inc. The agreement will largely track the terms of the Global Prescription Opioid Litigation Settlement Agreement that was announced on July 23, 2021.
Texas Attorney General Ken Paxton announced a $290 million statewide opioid settlement agreement with Johnson & Johnson to resolve opioid-related claims.
Following on his previous announcement, Attorney General Ken Paxton announced his intention to join the $21 billion opioid distributor settlement in a press conference on Thursday.
Attorney General Ken Paxton announced a historic $26 billion agreement that will bring desperately needed relief to Texans who are struggling with opioid addiction. The agreement includes Cardinal, McKesson, and AmerisourceBergen – the nation’s three major pharmaceutical distributors – and Johnson & Johnson, which manufactured and marketed opioids.
Purdue Pharma Files Bankruptcy Plan, Establishing Trust for Nationwide Opioid Abatement Efforts
Texas Attorney General Ken Paxton today announced that Purdue Pharma filed its estimated $7 billion bankruptcy plan, which places the value of the company into a trust set up to allocate funds toward opioid abatement efforts across the nation.
AG Paxton: Updated Settlement Reached with Opioid Manufacturer Mallinckrodt Following Company Bankruptcy
Attorney General Ken Paxton today announced an update to a global settlement framework agreement between state attorneys general, local subdivisions, and the opioid manufacturer Mallinckrodt (MNK), its subsidiaries, and other affiliates.
Attorney General Ken Paxton today announced a global settlement framework agreement between state attorneys general, local subdivisions, and Mallinckrodt (MNK), its subsidiaries, and certain other affiliates.
AG Paxton: All U.S. Attorneys General Call on Congress to Pass Bipartisan FIGHT Fentanyl Act
Attorney General Ken Paxton today joined all 56 attorneys general in calling for Congress to pass the bipartisan Federal Initiative to Guarantee Health by Targeting (FIGHT) Fentanyl Act.
Attorney General Ken Paxton Issues Statement on Chapter 11 Bankruptcy Filing of Purdue Pharma
Attorney General Paxton released the following statement in response to the Chapter 11 bankruptcy filing of Purdue Pharma and all affiliated U.S. companies in the United States Bankruptcy Court for the Southern District of New York.
Texas Attorney General Ken Paxton announced that his office filed a civil Medicaid fraud lawsuit against pharmaceutical manufacturer Johnson & Johnson, and its subsidiary Janssen Pharmaceuticals, Inc., for misrepresentations made to the Texas Medicaid program about their dangerous opioid drug, Duragesic.